Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 29;10(1):54-62.
doi: 10.3390/dermatopathology10010008.

Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls

Affiliations
Review

Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls

Celestine M Trinidad et al. Dermatopathology (Basel). .

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a dermal malignant mesenchymal tumor. Most variants are associated with a high risk of local recurrence and a low risk of metastasis. The classic histomorphology of this tumor is made up of uniform, spindle-shaped cells, arranged in a storiform pattern. Tumor cells characteristically infiltrate the underlying subcutis in a honeycomb pattern. Less common variants of DFSP have been identified: myxoid, pigmented, myoid, granular cell, sclerosing, atrophic, and fibrosarcomatous. Only the fibrosarcomatous variant has been shown to differ significantly from classic DFSP in terms of clinical outcome; fibrosarcomatous DFSP has been shown to be associated with a greater risk of local recurrence and metastatic potential than classic DFSP. However, the other variants may pose diagnostic difficulty as they resemble other types of spindle cell neoplasms, especially in small biopsy specimens. This article reviews the clinical, histologic, and molecular features of DFSP variants, as well as possible pitfalls in their diagnosis and how to resolve them.

Keywords: DFSP; clinical and molecular; histology; rare subtypes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
DFSP with classic histomorphology: dermal-based tumor with uniform, spindle-shaped cells ((A); magnification ×40) arranged in a predominantly storiform pattern ((B); magnification ×100 and (C); magnification ×200). These cells are primarily based in the dermis, with infiltration of the subcutis in a characteristic diffuse honeycomb fashion (B). In immunohistochemistry, DFSP shows strong and diffuse positive staining for CD34 ((D); magnification ×200).
Figure 2
Figure 2
Myxoid DFSP. In this variant, characteristic storiform growth of DFSP is often lost, and the blood vessels are more prominent. However, honeycomb pattern of infiltration into subcutaneous fat can still be seen ((A); magnification ×100 and (B); magnification ×40). Nuclei are plump, wavy, and uniform with focal or diffuse myxoid change ((C); magnification ×100).
Figure 3
Figure 3
Pigmented DFSP (Bednar tumor). Occasionally, DFSP can show areas of melanocytes containing melanin pigments ((A); magnification ×40 and (B); magnification ×200). The tumor otherwise shows characteristic features of DFSP. This feature has no prognostic importance.
Figure 4
Figure 4
Myoid DFSP. Stromal vessels can have myointimal hyperplasia resulting in myoid nodules ((A); magnification ×40), which is not a usual feature in conventional DFSP—more common in DFSP with fibrosarcomatous transformation. The cell myoid nodules have more abundant bright eosinophilic cytoplasm with cigar-shaped nuclei—catachrestic of smooth muscle differentiation with SMA expression ((B); magnification ×100). They are positive for SMA.
Figure 5
Figure 5
Fibrosarcomatous DFSP. Fibrosarcomatous transformation is characterized by areas showing increased cellularity and herringbone architecture, reminiscent of fibrosarcoma ((A); magnification ×40). This finding represents transformation to higher-grade tumor and carries a risk of metastasis. Mitotic rate can be increased ((B); magnification ×100) and necrosis can be occasionally present. However, these two features are not required for diagnosis.

References

    1. Elder D.E., Massi D., Scolyer R.A., International Agency for Research on Cancer . WHO Classification of Skin Tumours. International Agency for Research on Cancer; Lyon, France: 2018.
    1. Mentzel T., Schärer L., Kazakov D.V., Michal M. Myxoid dermatofibrosarcoma protuberans: Clinicopathologic, immunohistochemical, and molecular analysis of eight cases. Am. J. Dermatopathol. 2007;29:443–448. doi: 10.1097/DAD.0b013e318145413c. - DOI - PubMed
    1. Socoliuc C., Zurac S., Andrei R., Stăniceanu F. Multiple Histological Subtypes of Dermatofibrosarcoma Protuberans Occurring in the Same Tumor. Rom. J. Intern. Med. 2015;53:79–88. doi: 10.1515/rjim-2015-0011. - DOI - PubMed
    1. Patel K.U., Szabo S.S., Hernandez V.S., Prieto V.G., Abruzzo L.V., Lazar A.J., López-Terrada D. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum. Pathol. 2008;39:184–193. - PubMed
    1. Cloutier J.M., Allard G., Bean G.R., Hornick J.L., Charville G.W. PDGFB RNA in situ hybridization for the diagnosis of dermatofibrosarcoma protuberans. Mod. Pathol. 2021;34:1521–1529. doi: 10.1038/s41379-021-00800-2. - DOI - PMC - PubMed

LinkOut - more resources